Researcher Stories
Get to know the PhRMA Foundation’s award recipients.
Reprogramming Immune Cells From Cancer Allies to Cancer Fighters
Dr. Anastasia Varanko, a postdoctoral trainee at Vanderbilt University, aims to make existing immunotherapies more effective to expand their benefit to a broader range of patients and cancer types.
Watch Now
Using AI to Predict Which Cancer Mutations Matter
Jessica White, a PhD candidate at Memorial Sloan Kettering Cancer Center, is using AI and genomic data from cancer patients to identify overlooked mutations and help more people benefit from precision medicine.
Read More
Measuring the Hidden Impact of Stigma in Sickle Cell Disease
As a PhD student at The University of Texas at Austin, Ayobami Aiyeolemi is developing a first-of-its-kind tool to measure sickle cell disease stigma and improve patient care.
Read MoreCombining Immunotherapy and Chemotherapy for Better Cancer Treatment
Kaitlyn Pierpont, a PhD student at Weill Cornell Medicine, is researching how to improve cancer treatment by combining two therapies: chemotherapy and chimeric antigen receptor (CAR) T-cell therapy.
Awardee Spotlight
Kate Bowman
- University of Michigan
“I am immensely grateful to the PhRMA Foundation for supporting not only my research but also my scientific career. The predoctoral fellowship will propel me further into the world of drug discovery and the innovation of novel translational treatments.”
How Checking the Wrong Box Led to the Right Career Path in Cancer Research
Ahmad Salman Sirajee, a PhD student at Rutgers University, is developing a noninvasive diagnostic tool that identifies patterns of DNA fragments in the bloodstream to help doctors better classify and monitor bladder cancer patients.